Burjeel’s first-half revenues reach Dhs 2.4 billion, up 10.4%
Picture used for illustrative purposes only.
Outpatient and inpatient revenue increased by Dhs 137 million and Dhs 82 million, respectively, the group said in a statement today.
Group earnings before interest, taxes, depreciation and amortisation (EBITDA) ex-one-offs increased by 2.2 percent to Dhs 477 million, despite higher direct costs from continued investment in oncology to boost revenues as a result of growing patient uptake in the future. This was despite higher direct costs resulting from continued investment in oncology to boost revenue from future patient demand.
The Group’s net profit ex-one-offs and taxes increased by 5.9 percent to Dhs 238 million on the back of revenue growth and lower finance and amortisation costs.
